Clinical trial Recruiting at 5 sites Interventional Ages 30 to 65

High-intensity focused ultrasound lift for loose submental and neck skin

Official title: A Prospective, Multi-center, Randomized Controlled, Non-inferiority Study to Evaluate the Safety and Effectiveness of ULTRAFORMER MPT PLUS Treatment to Lift Lax Submental (Beneath the Chin) and Neck Tissue

Run by CLASSYS Inc. · NCT07229430 · Data updated 2026-11-12

This study will test whether the ULTRAFORMER MPT PLUS device can lift and tighten mild-to-moderate loose skin under the chin and on the neck in adults aged 30 to 65.

More Skin Laxity trials

Quick facts

Study typeInterventional
Ages30 Years to 65 Years
SexAll
Enrollment273 (estimated)
SponsorCLASSYS Inc.
Industry-sponsored
Locations5 sites (Los Angeles, California and 4 other locations)
StatusRecruiting
StartedOctober 16, 2025
Main results expectedNovember 26, 2026
Study endsNovember 26, 2026
Registry record updatedApril 20, 2026
Trial IDNCT07229430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 30–65 with mild-to-moderate submental or neck skin laxity, stable body weight, and no recent cosmetic procedures to the treatment area.

Probably not a fit

People with severe laxity, prior facelift/neck surgery, or recent energy-based or injectable treatments to the lower face or neck are unlikely to benefit from this device in this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter, randomized, evaluator-blinded, parallel-controlled non-inferiority study compares ULTRAFORMER MPT PLUS to the approved Ulthera System for improving submental and neck skin laxity. Approximately 273 adults aged 30–65 with mild-to-moderate laxity will be randomized 1:1 across up to five U.S. investigational sites, with two initial safety stages before a pivotal Stage 2. Primary endpoints include blinded investigator improvement on the Facial Laxity Grading Scale and device-related adverse events, with secondary endpoints of patient-reported outcomes, digital image analysis, and durability at 8- and 12-week follow-ups. Treatments are delivered by trained investigators under an FDA IDE with oversight by an independent Data Safety Monitoring Board.

Why it matters

Potential benefit: If successful, the device could provide a non-surgical option to reduce submental and neck laxity comparable to an existing approved HIFU system.

How similar studies have gone: Previous studies and the approved Ulthera HIFU system have shown benefit for skin tightening, so this trial compares a newer HIFU device against that established approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female subjects aged 30 to 65 years, inclusive, at the time of informed consent.
2. Subjects presenting with mild to moderate submental and/or neck skin laxity, as determined by the investigator.
3. Subjects in good general health with stable body weight (±5%) for at least 6 months prior to screening.
4. Subjects willing to avoid other aesthetic or dermatologic procedures (surgical or non-surgical) to the treatment area during the study period.
5. Subjects able to understand and sign informed consent and comply with all study visits and procedures.
6. Female subjects of child-bearing potential who agree to use reliable contraception throughout study participation.

Exclusion Criteria:

1. Prior facelift, neck lift, liposuction, or contouring surgery involving the lower face, submental, or neck areas.
2. Receipt of any energy-based aesthetic treatment (e.g., HIFU, radiofrequency, laser) or injectable aesthetic treatment (e.g., botulinum toxin, dermal filler, collagen stimulator) to the treatment area within 6 months prior to baseline.
3. Presence of any implanted electronic medical device, such as a pacemaker, defibrillator, or neurostimulator.
4. Active skin infection, wound, cystic acne, inflammation, or severe scarring within or near the treatment area.
5. History of keloid formation or abnormal wound healing.
6. Known bleeding disorder, or use of anticoagulant or antiplatelet medications that cannot be safely discontinued for the procedure.
7. Pregnant or breastfeeding women.
8. Subjects with a known sensitivity or contraindication to ultrasound-based procedures.
9. Any medical or psychiatric condition that, in the investigator's judgment, could interfere with study participation, safety, or data integrity.
10. Participation in another investigational study within 30 days prior to screening.

Where it's running

  • Dermatology
    Los Angeles, California, United States
    Recruiting
  • Dermatology
    Charlotte, North Carolina, United States
    Recruiting
  • Dermatology
    Wilmington, North Carolina, United States
    Recruiting
  • Dermatology
    Nashville, Tennessee, United States
    Recruiting
  • Dermatology
    Spokane, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.